Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Net Cash Flow: 2011-2024

Historic Net Cash Flow for Agios Pharmaceuticals (AGIO) over the last 14 years, with Dec 2024 value amounting to -$12.0 million.

  • Agios Pharmaceuticals' Net Cash Flow fell 93.00% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$161.0 million, marking a year-over-year decrease of 185.02%. This contributed to the annual value of -$12.0 million for FY2024, which is 76.58% up from last year.
  • Per Agios Pharmaceuticals' latest filing, its Net Cash Flow stood at -$12.0 million for FY2024, which was up 76.58% from -$51.1 million recorded in FY2023.
  • Agios Pharmaceuticals' 5-year Net Cash Flow high stood at $75.7 million for FY2021, and its period low was -$63.9 million during FY2022.
  • In the last 3 years, Agios Pharmaceuticals' Net Cash Flow had a median value of -$51.1 million in 2023 and averaged -$42.3 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first surged by 347.48% in 2020, then tumbled by 184.38% in 2022.
  • Over the past 5 years, Agios Pharmaceuticals' Net Cash Flow (Yearly) stood at $47.3 million in 2020, then spiked by 59.99% to $75.7 million in 2021, then plummeted by 184.38% to -$63.9 million in 2022, then climbed by 20.06% to -$51.1 million in 2023, then spiked by 76.58% to -$12.0 million in 2024.